Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211899 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Iasmim Lopes de Lima und 16 weiteren Autor:innen. Beteiligte Einrichtung: PPGEMN, School of Engineering, Mackenzie Presbyterian University, São Paulo 01302-907, SP, Brazil. Hauptthemen laut MEDLINE: COVID-19, Saliva, Metabolomics, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Coordination of Improvement of Higher Education Personnel—Brazil (CAPES), São Paulo Research Foundation (FAPESP).
Abstract (Originalsprache)
Omics approaches were extensively applied during the coronavirus disease 2019 (COVID-19) pandemic to understand the disease, identify biomarkers with diagnostic and prognostic value, and discover new molecular targets for medications. COVID-19 continues to challenge the healthcare system as the virus mutates, becoming more transmissible or adept at evading the immune system, causing resurgent epidemic waves over the last few years. In this study, we used saliva from volunteers who were negative and positive for COVID-19 when Omicron and its variants became dominant. We applied a direct solid-phase extraction approach followed by non-target metabolomics analysis to identify potential salivary signatures of hospital-recruited volunteers to establish a model for COVID-19 screening. Our model, which aimed to differentiate COVID-19-positive individuals from controls in a hospital setting, was based on 39 compounds and achieved high sensitivity (85%/100%), specificity (82%/84%), and accuracy (84%/92%) in training and validation sets, respectively. The salivary diagnostic signatures were mainly composed of amino acids and lipids and were related to a heightened innate immune antiviral response and an attenuated inflammatory profile. The higher abundance of thyrotropin-releasing hormone in the COVID-19 positive group highlighted the endocrine imbalance in low-severity disease, as first reported here, underscoring the need for further studies in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PPGEMN, School of Engineering, Mackenzie Presbyterian University, São Paulo 01302-907, SP, Brazil.
- MackGraphe-Mackenzie Institute for Research in Graphene and Nanotechnologies, Mackenzie Presbyterian Institute, São Paulo 01302-907, SP, Brazil.
- MS4Life Laboratory of Mass Spectrometry, Health Sciences Postgraduate Program, São Francisco University-USF, Bragança Paulista 12916-900, SP, Brazil.
- LAPI-Laboratory of Research in Infectology, University Hospital Professor Edgard Santos (HUPES), Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil.
- BIOINOVAR-Biotechnology Laboratories, Biocatalysis, Bioproducts and Bioenergy, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil.
- Department of Genetics, Luiz de Queiroz College of Agriculture, University of São Paulo (USP/ESALQ), Piracicaba 13418-900, SP, Brazil.
ORCID-Profile: Iasmim Lopes de Lima, Alex Ap Rosini Silva, Carlos Brites, Natália Angelo da Silva Miyaguti, Felipe Raposo Passos Mansoldo, Pedro Henrique Godoy Sanches, Thais Regiani Cataldi, Alane Beatriz Vermelho, Andreia M Porcari
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Coordination of Improvement of Higher Education Personnel—Brazil (CAPES)
- São Paulo Research Foundation (FAPESP)
Zitieren
APA
Lopes de Lima, I., Ap Rosini Silva, A., Brites, C., Angelo da Silva Miyaguti, N., Raposo Passos Mansoldo, F., Vaz Nunes, S., Henrique Godoy Sanches, P., Regiani Cataldi, T., Pais de Carvalho, C., Reis da Silva, A., Ribeiro da Rosa, J., Magalhães Borges, M., Vilarindo Oliveira, W., Canevari, T. C., Beatriz Vermelho, A., Nogueira Eberlin, M., & M Porcari, A. (2024). Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211899
Vancouver
Lopes de Lima I, Ap Rosini Silva A, Brites C, Angelo da Silva Miyaguti N, Raposo Passos Mansoldo F, Vaz Nunes S, et al. Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211899
BibTeX
@article{LopesdeLima2024,
author = {Lopes de Lima, Iasmim and Ap Rosini Silva, Alex and Brites, Carlos and Angelo da Silva Miyaguti, Natália and Raposo Passos Mansoldo, Felipe and Vaz Nunes, Sara and Henrique Godoy Sanches, Pedro and Regiani Cataldi, Thais and Pais de Carvalho, Caroline and Reis da Silva, Adriano and Ribeiro da Rosa, Jonas and Magalhães Borges, Mariana and Vilarindo Oliveira, Wellisson and Canevari, Thiago Cruz and Beatriz Vermelho, Alane and Nogueira Eberlin, Marcos and M Porcari, Andreia},
title = {Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211899}
}
EUVIMED